Drugs / GDC-0334
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03381144 | Dec 2017 → Apr 2019 | — | Genentech, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GDC-0334 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03381144 ↗ |
| Route | Oral | “GDC-0334 given orally” NCT03381144 ↗ |